Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.

[1]  F. Escorcia,et al.  External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma , 2016, Expert review of anticancer therapy.

[2]  James J. Evans,et al.  Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas , 2016, Journal of Neuro-Oncology.

[3]  G. Kanyilmaz,et al.  Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas. , 2015, Annals of translational medicine.

[4]  H. Wheeler,et al.  Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma. , 2015, Neuro-oncology practice.

[5]  V. Esposito,et al.  Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas , 2015, Journal of Neuro-Oncology.

[6]  James J. Evans,et al.  A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma. , 2014, International journal of radiation oncology, biology, physics.

[7]  C. Brennan,et al.  Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma , 2014, Clinical Cancer Research.

[8]  F. Zorlu,et al.  Hypofractionated stereotactic reirradiation for recurrent glioblastoma , 2014, Journal of Neuro-Oncology.

[9]  M. Osman.  Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas. , 2014, Annals of translational medicine.

[10]  R. Guerrero-Tejada,et al.  Salvage Radiosurgery for Selected Patients with Recurrent Malignant Gliomas , 2014, BioMed research international.

[11]  K. Aldape,et al.  A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[12]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[13]  J. Tonn,et al.  Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option , 2014, Journal of Neuro-Oncology.

[14]  L. Deangelis,et al.  Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.

[15]  M. Hiraoka,et al.  Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control , 2013, Cancer medicine.

[16]  M. Iori,et al.  Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience , 2013, Radiation Oncology.

[17]  H. Ishikawa,et al.  Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy , 2013, Strahlentherapie und Onkologie.

[18]  S. Yoon,et al.  Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma , 2013, Tumori.

[19]  R. Warnick,et al.  Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas , 2013, Journal of Neuro-Oncology.

[20]  Y. Yamada,et al.  Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma. , 2013, International journal of radiation oncology, biology, physics.

[21]  Michael R. Green,et al.  A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. , 2013, International journal of radiation oncology, biology, physics.

[22]  P. Gutin,et al.  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. , 2012, European journal of cancer.

[23]  Hae-June Lee,et al.  Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials. , 2012, Current angiogenesis.

[24]  C. Willett,et al.  Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. , 2012, International journal of radiation oncology, biology, physics.

[25]  D. Amelio,et al.  Radiation Therapy for the Treatment of Recurrent Glioblastoma: An Overview , 2012, Cancers.

[26]  Francesco Tomasello,et al.  Efficacy and toxicity of CyberKnife re-irradiation and “dose dense” temozolomide for recurrent gliomas , 2012, Acta Neurochirurgica.

[27]  M. Gilbert,et al.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. , 2011, International journal of radiation oncology, biology, physics.

[28]  T. Cloughesy,et al.  AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme , 2011, Advances in therapy.

[29]  C. Giorgi,et al.  Treatment of Recurrent Glioblastoma with Stereotactic Radiotherapy: Long-Term Results of a Mono-Institutional Trial , 2011, Tumori.

[30]  T. Mikkelsen,et al.  Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Jenghwa Chang,et al.  Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. , 2009, International journal of radiation oncology, biology, physics.

[32]  E. Fokas,et al.  Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas , 2009, Strahlentherapie und Onkologie.

[33]  L. Gaspar,et al.  Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. , 2009, International journal of radiation oncology, biology, physics.

[34]  C. Belka,et al.  Hypofractionated reirradiation for recurrent malignant glioma , 2009, Strahlentherapie und Onkologie.

[35]  J. Debus,et al.  Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas , 2008, Journal of Neuro-Oncology.

[36]  J. Debus,et al.  Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  K. Bratengeier,et al.  Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma , 2005, BMC Cancer.

[38]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[39]  Morand Piert,et al.  Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[40]  W. Curran,et al.  A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. , 1999, International journal of radiation oncology, biology, physics.

[41]  R. Laing,et al.  Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. , 1997, International journal of radiation oncology, biology, physics.

[42]  J. Tonn,et al.  Irradiation and bevacizumab in high-grade glioma retreatment settings. , 2012, International journal of radiation oncology, biology, physics.

[43]  A. Omuro,et al.  Complications of radiotherapy to the central nervous system. , 2012, Handbook of clinical neurology.

[44]  V. Esposito,et al.  Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas , 2012, Journal of Neuro-Oncology.

[45]  J. Uhm.  Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas , 2011 .

[46]  J. Uhm.  Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .

[47]  T. Mikkelsen,et al.  Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival , 2008, Journal of Neuro-Oncology.